Cameron Pitt
Executive Officer and Director at Quanta Therapeutics.
Earliest Form D on file: Jun 2026
Filed Jun 24, 2026Amendment
Quanta Therapeutics
Oral KRAS G12D and G12V inhibitors for cancer
Biotech, South San Francisco CA
Named, Executive Officer, Director.
Network
At Quanta Therapeutics
6 peopleExecutive Officer, Director, signed as Chief Executive Officer
Executive Officer
Director
Director
Director
Director